Hortobagyi GN - Search Results

1

Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR⁺, HER2^- advanced breast cancer: results from BOLERO-2.

Moynahan ME, Chen D, He W, Sung P, Samoila A, You D, Bhatt T, Patel P, Ringeisen F, Hortobagyi GN, Baselga J, Chandarlapaty S. Moynahan ME, et al. Among authors: hortobagyi gn. Br J Cancer. 2017 Mar 14;116(6):726-730. doi: 10.1038/bjc.2017.25. Epub 2017 Feb 9. Br J Cancer. 2017. PMID: 28183140 Free PMC article. Clinical Trial.

2

Bone metastasis in breast cancer.

Theriault RL, Hortobagyi GN. Theriault RL, et al. Among authors: hortobagyi gn. Anticancer Drugs. 1992 Oct;3(5):455-62. doi: 10.1097/00001813-199210000-00002. Anticancer Drugs. 1992. PMID: 1450438 Review.

3

Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma.

Singletary SE, McNeese MD, Hortobagyi GN. Singletary SE, et al. Among authors: hortobagyi gn. Cancer. 1992 Jun 1;69(11):2849-52. doi: 10.1002/1097-0142(19920601)69:11<2849::aid-cncr2820691134>3.0.co;2-p. Cancer. 1992. PMID: 1571916

4

Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis.

Sahin AA, Ro J, Ro JY, Blick MB, el-Naggar AK, Ordonez NG, Fritsche HA, Smith TL, Hortobagyi GN, Ayala AG. Sahin AA, et al. Among authors: hortobagyi gn. Cancer. 1991 Aug 1;68(3):549-57. doi: 10.1002/1097-0142(19910801)68:3<549::aid-cncr2820680318>3.0.co;2-j. Cancer. 1991. PMID: 1648433

5

Lack of correlation between histologic findings and response to chemotherapy in metastatic breast cancer.

Ziegler LD, Connelly JH, Frye D, Smith TL, Hortobagyi GN. Ziegler LD, et al. Among authors: hortobagyi gn. Cancer. 1991 Aug 1;68(3):628-33. doi: 10.1002/1097-0142(19910801)68:3<628::aid-cncr2820680331>3.0.co;2-3. Cancer. 1991. PMID: 1648436

6

Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy.

Buzdar AU, Kau SW, Hortobagyi GN, Ames FC, Holmes FA, Fraschini G, Hug V, Theriault RL, McNeese MD, Singletary SE. Buzdar AU, et al. Among authors: hortobagyi gn. Cancer. 1992 Jan 15;69(2):448-52. doi: 10.1002/1097-0142(19920115)69:2<448::aid-cncr2820690229>3.0.co;2-k. Cancer. 1992. PMID: 1728373

7

A randomized trial of two dosage schedules of mitomycin C in advanced breast carcinoma.

Walters RS, Frye D, Buzdar AU, Holmes FA, Hortobagyi GN. Walters RS, et al. Among authors: hortobagyi gn. Cancer. 1992 Jan 15;69(2):476-81. doi: 10.1002/1097-0142(19920115)69:2<476::aid-cncr2820690234>3.0.co;2-0. Cancer. 1992. PMID: 1728377 Clinical Trial.

8

Phase II evaluation of interferon added to tamoxifen in the treatment of metastatic breast cancer.

Macheledt JE, Buzdar AU, Hortobagyi GN, Frye DK, Gutterman JU, Holmes FA. Macheledt JE, et al. Among authors: hortobagyi gn. Breast Cancer Res Treat. 1991 Aug;18(3):165-70. doi: 10.1007/BF01990032. Breast Cancer Res Treat. 1991. PMID: 1756259 Clinical Trial.

9

Adrenal failure in patients with breast carcinoma after long-term treatment of cyclic alternating oestrogen progesterone.

Hug V, Kau S, Hortobagyi GN, Jones L. Hug V, et al. Among authors: hortobagyi gn. Br J Cancer. 1991 Mar;63(3):454-6. doi: 10.1038/bjc.1991.105. Br J Cancer. 1991. PMID: 1825919 Free PMC article. No abstract available.

10

Comprehensive management of locally advanced breast cancer.

Hortobagyi GN. Hortobagyi GN. Cancer. 1990 Sep 15;66(6 Suppl):1387-91. doi: 10.1002/1097-0142(19900915)66:14+<1387::aid-cncr2820661414>3.0.co;2-i. Cancer. 1990. PMID: 2205369 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,106 results

Search Page

Filters